Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
A recent regulation proposed by the New Jersey Attorney General might affect the state's availability of clinical trials.
A year after launching its Japanese business, Clinigen has bought Japan’s largest supplier of unlicensed medicines.
OmniComm signed its seventh client in China that uses its phase 1 EDC system TrialOne.
It can be seriously disruptive when the site investigator for your trial leaves or decides to step down, but new recommendations from the Clinical Trials…
Elligo Health Research will test a harmonized real-word data model built by the FDA.
As part of our video series for this year’s DDF 2017 event, life science leaders spoke to us about CRO needs and new regulations.
PPD has taken on a former FDA veteran, Jonca Bull, M.D., as its new VP of PPD consulting and ophthalmology within global product development.
Biopharma executives share how they manage outsourcing relationships at this year's Drug Development Forum.
Parexel has set up a team committed to providing real-world data insights.
The FDA and its new Trump-picked commissioner Scott Gottlieb took to social media to talk up plans to speed up the drug regulation process.